• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《芝加哥腹膜表面恶性肿瘤共识:卵巢肿瘤的处理》。

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms.

出版信息

Ann Surg Oncol. 2020 Jun;27(6):1780-1787. doi: 10.1245/s10434-020-08322-y. Epub 2020 Apr 13.

DOI:10.1245/s10434-020-08322-y
PMID:32285271
Abstract

The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of ovarian neoplasms specifically related to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, gynecologic oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence.

摘要

芝加哥共识工作组提供了针对卵巢肿瘤管理的多学科建议,特别是与腹膜表面恶性肿瘤管理相关的建议。这些指南是在包括外科肿瘤学家、内科肿瘤学家、妇科肿瘤学家、病理学家、放射科医生、姑息治疗医生和药剂师在内的领先专家的投入下制定的。这些指南认识到并解决了在腹膜表面疾病的适当管理方面提高认识的需求。它们并不是为了取代对更高水平证据的追求。

相似文献

1
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms.《芝加哥腹膜表面恶性肿瘤共识:卵巢肿瘤的处理》。
Ann Surg Oncol. 2020 Jun;27(6):1780-1787. doi: 10.1245/s10434-020-08322-y. Epub 2020 Apr 13.
2
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors.《芝加哥腹膜表面恶性肿瘤共识:神经内分泌肿瘤的处理》。
Ann Surg Oncol. 2020 Jun;27(6):1788-1792. doi: 10.1245/s10434-020-08321-z. Epub 2020 Apr 13.
3
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases.《芝加哥腹膜表面恶性肿瘤共识:胃转移瘤的处理》。
Ann Surg Oncol. 2020 Jun;27(6):1768-1773. doi: 10.1245/s10434-020-08320-0. Epub 2020 Apr 13.
4
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms.《腹膜表面恶性肿瘤芝加哥共识:阑尾肿瘤的处理》。
Ann Surg Oncol. 2020 Jun;27(6):1753-1760. doi: 10.1245/s10434-020-08316-w. Epub 2020 Apr 13.
5
The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations.《芝加哥腹膜表面恶性肿瘤共识:姑息治疗考虑》。
Ann Surg Oncol. 2020 Jun;27(6):1798-1804. doi: 10.1245/s10434-020-08323-x. Epub 2020 Apr 13.
6
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma.《芝加哥腹膜表面恶性肿瘤共识:腹膜间皮瘤的处理》。
Ann Surg Oncol. 2020 Jun;27(6):1774-1779. doi: 10.1245/s10434-020-08324-w. Epub 2020 Apr 13.
7
The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms.《芝加哥腹膜表面恶性肿瘤共识:卵巢肿瘤的处理》。
Cancer. 2020 Jun 1;126(11):2553-2560. doi: 10.1002/cncr.32867. Epub 2020 Apr 13.
8
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases.《芝加哥腹膜表面恶性肿瘤共识:结直肠转移瘤的处理》。
Ann Surg Oncol. 2020 Jun;27(6):1761-1767. doi: 10.1245/s10434-020-08315-x. Epub 2020 Apr 13.
9
The Chicago Consensus on Peritoneal Surface Malignancies: Methodology.《腹膜表面恶性肿瘤芝加哥共识:方法学》
Ann Surg Oncol. 2020 Jun;27(6):1741-1742. doi: 10.1245/s10434-020-08317-9. Epub 2020 Apr 13.
10
The Chicago Consensus on Peritoneal Surface Malignancies: Standards.《芝加哥腹膜表面恶性肿瘤共识:标准》。
Ann Surg Oncol. 2020 Jun;27(6):1743-1752. doi: 10.1245/s10434-020-08325-9. Epub 2020 Apr 13.

引用本文的文献

1
Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond.结直肠癌腹膜表面转移的管理:细胞减灭术、腹腔内热灌注化疗、腹腔加压化疗及其他。
Front Oncol. 2022 Nov 8;12:992030. doi: 10.3389/fonc.2022.992030. eCollection 2022.

本文引用的文献

1
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.新辅助化疗与中间型减瘤术治疗晚期输卵管-卵巢癌:来自 EORTC 55971 和 CHORUS 试验的个体患者数据的汇总分析。
Lancet Oncol. 2018 Dec;19(12):1680-1687. doi: 10.1016/S1470-2045(18)30566-7. Epub 2018 Nov 6.
2
Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer.腹腔镜评分算法与晚期卵巢癌初次手术发现的一致性。
Gynecol Oncol. 2018 Dec;151(3):428-432. doi: 10.1016/j.ygyno.2018.10.017. Epub 2018 Oct 23.
3
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
奥拉帕利维持治疗新诊断的晚期卵巢癌患者。
N Engl J Med. 2018 Dec 27;379(26):2495-2505. doi: 10.1056/NEJMoa1810858. Epub 2018 Oct 21.
4
Laparoscopy and Computed Tomography Imaging in Advanced Ovarian Tumors: A Roadmap for Prediction of Optimal Cytoreductive Surgery.晚期卵巢肿瘤的腹腔镜检查与计算机断层扫描成像:最佳肿瘤细胞减灭术预测路线图
Gynecol Minim Invasive Ther. 2018 Apr-Jun;7(2):66-69. doi: 10.4103/GMIT.GMIT_1_17. Epub 2018 May 2.
5
Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE.罕见卵巢来源腹膜癌经细胞减灭术和腹腔热灌注化疗治疗:来自 PSOGI 和 BIG-RENAPE 的多机构队列研究。
Ann Surg Oncol. 2018 Jun;25(6):1668-1675. doi: 10.1245/s10434-018-6464-z. Epub 2018 Apr 10.
6
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin.阑尾和阑尾外来源的假性黏液瘤的细胞减灭术和腹腔内热化疗。
Br J Surg. 2018 May;105(6):668-676. doi: 10.1002/bjs.10716. Epub 2018 Feb 7.
7
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.腹腔内热灌注化疗治疗卵巢癌。
N Engl J Med. 2018 Jan 18;378(3):230-240. doi: 10.1056/NEJMoa1708618.
8
OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer.OV21/PETROC:一项新辅助化疗和最佳肿瘤细胞减灭术后腹腔内与静脉化疗在卵巢上皮癌中的随机妇科癌症协作组 II 期研究。
Ann Oncol. 2018 Feb 1;29(2):431-438. doi: 10.1093/annonc/mdx754.
9
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.芦卡帕利维持治疗铂类化疗后缓解的复发性卵巢癌(ARIEL3):一项随机、双盲、安慰剂对照、III 期临床试验。
Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12.
10
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.奥拉帕利片作为 BRCA1/2 突变的铂敏感复发性卵巢癌患者的维持治疗(SOLO2/ENGOT-Ov21):一项双盲、随机、安慰剂对照、III 期临床试验。
Lancet Oncol. 2017 Sep;18(9):1274-1284. doi: 10.1016/S1470-2045(17)30469-2. Epub 2017 Jul 25.